NRG Oncology
Formed to conduct oncologic clinical research and to broadly disseminate study results for informing clinical decision making and healthcare policy. It brings together the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)—each recognized internationally as a research leader.
Content by NRG Oncology
|2 min read
Two Potential Drug Targets Identified in Cervical Cancer Trial
ARID1A and PIK3CA could serve as potential targets for drug development
|2 min read
NRG Oncology Launches FORTE, a Colorectal Cancer Prevention Clinical Trial
FORTE is a large, randomized trial of surveillance colonoscopy for participants with one or two small benign polypsPage 1 of 1
